Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?

INTRODUCTION: Cerebrospinal fluid (CSF) neurodegenerative markers are measured clinically to support a diagnosis of Alzheimer's disease. Several preanalytical factors may alter the CSF concentrations of amyloid β 1–42 (Aβ1–42) in particular with the potential to influence diagnosis. We aimed to...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alzheimers Dement (Amst)
Главные авторы: Paterson, Ross W., Toombs, Jamie, Chapman, Miles D., Nicholas, Jennifer M., Heslegrave, Amanda J., Slattery, Catherine F., Foulkes, Alexander J.M., Clark, Camilla N., Lane, Christopher A.S., Weston, Philip S.J., Lunn, Michael P., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2015
Предметы:
CSF Biomarkers
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877931/
https://ncbi.nlm.nih.gov/pubmed/27239518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.003
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы